EUVIMEDEUVIMED entdecken
Open Access

Bile acid sequestrant inhibits gluconeogenesis via inducing hepatic cysteine dioxygenase type 1 to reduce cysteine availability

David J Matye, Huaiwen Wang, Yifeng Wang, Lei Xiong, Tiangang Li iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025

DOI: 10.1152/ajpgi.00353.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von David J Matye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Physiology, Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, Unite…. Hauptthemen laut MEDLINE: Cysteine, Cysteine Dioxygenase, Gluconeogenesis, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic cysteine availability is a key driver of hepatic gluconeogenesis. Bile acid sequestrant inhibits gluconeogenesis by inducing CDO1-mediated cysteine catabolism to reduce cysteine availability. Dietary protein restriction causes hepatic cysteine deficiency without overall amino acid deficiency. The glucose-lowering effect of dietary protein restriction is largely mediated by lower dietary cysteine intake. The anti-obesity effect of chronic dietary protein restriction is largely mediated by lower dietary cysteine intake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CysteineCysteine DioxygenaseGluconeogenesisLiverBile Acids and SaltsCholestyramine ResinAnimalsMiceMaleMice, Inbred C57BLHepatocytesHumans

Stichwörter der Autor:innen

CDO1FXRcholestyraminedietary protein restrictionglucose

Substanzen

CysteineCysteine DioxygenaseBile Acids and SaltsCholestyramine Resin

Autor:innen und Institutionen

  • Department of Biochemistry and Physiology, Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States.
  • Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, United States.
  • Laboratory for Molecular Biology and Cytometry Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States.

ORCID-Profile: Tiangang Li

Förderung

  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Zitieren

APA

Matye, D. J., Wang, H., Wang, Y., Xiong, L., & Li, T. (2025). Bile acid sequestrant inhibits gluconeogenesis via inducing hepatic cysteine dioxygenase type 1 to reduce cysteine availability. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00353.2024

Vancouver

Matye DJ, Wang H, Wang Y, Xiong L, Li T. Bile acid sequestrant inhibits gluconeogenesis via inducing hepatic cysteine dioxygenase type 1 to reduce cysteine availability. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00353.2024

BibTeX
@article{Matye2025,
  author = {Matye, David J and Wang, Huaiwen and Wang, Yifeng and Xiong, Lei and Li, Tiangang},
  title = {Bile acid sequestrant inhibits gluconeogenesis via inducing hepatic cysteine dioxygenase type 1 to reduce cysteine availability},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2025},
  doi = {10.1152/ajpgi.00353.2024}
}
Kostenlos starten →